Position in BMY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,536,729,084
-$68,719,959 QoQ
Shares Held
26,670,064
+0.8% QoQ
Ownership
1.31%
of shares outstanding
% of Portfolio
0.39%
of 13F equity value
Holder Rank
#13
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 74%
None 26%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AMERIPRISE FINANCIAL INC holds $17,081,497,167 across 17 Drug Manufacturers - General names. BMY ranks #5 (9.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,996,669 | $3,594,294,994 | |
| 2 | JNJ |
Johnson & Johnson
|
13,401,691 | $3,403,627,461 | |
| 3 | ABBV |
AbbVie Inc.
|
11,519,507 | $2,898,768,740 | |
| 4 | MRK |
Merck & Co., Inc.
|
17,387,435 | $2,234,285,396 | |
| 5 | BMY |
Bristol Myers Squibb Co
This page
|
26,670,064 | $1,536,729,084 | |
| 6 | AZN |
Astrazeneca PLC
|
6,095,430 | $1,155,815,432 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
7,618,082 | $962,468,477 | |
| 8 | AMGN |
Amgen Inc
|
1,897,321 | $687,057,877 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,536,729,084 | 26,670,064 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,605,449,043 | 26,470,718 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,513,483,902 | 28,058,656 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,464,569,910 | 32,473,834 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,508,110,514 | 32,579,618 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,960,673,581 | 32,147,460 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $1,814,402,150 | 32,079,246 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,038,280,185 | 20,067,263 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $733,556,638 | 17,663,295 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,071,784,038 | 19,763,674 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,423,550,332 | 27,744,111 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,495,230,017 | 25,762,061 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,709,904,943 | 26,738,154 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,807,900,473 | 26,084,266 | Shares | Defined | 2023-05-22 | |
| 2022-12-31 | $1,701,218,318 | 23,644,452 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,751,759,111 | 24,641,428 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,931,000,533 | 25,077,929 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,959,246,719 | 26,827,971 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,744,725,706 | 27,982,770 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,685,814,301 | 28,491,031 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,019,028,974 | 30,215,938 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,909,826,497 | 30,252,281 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,783,618,620 | 28,754,129 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $1,772,226,356 | 29,395,030 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $1,853,605,258 | 31,523,899 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,681,123,692 | 30,160,095 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||